| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.001 | 1 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0015 | 1 |